Rank | Gene Set | Z-score |
---|---|---|
1 | leukocyte aggregation (GO:0070486) | 6.96005020 |
2 | activation of MAPKKK activity (GO:0000185) | 6.37302984 |
3 | positive regulation of defense response to virus by host (GO:0002230) | 5.13906081 |
4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.52440249 |
5 | type I interferon signaling pathway (GO:0060337) | 4.42677404 |
6 | cellular response to type I interferon (GO:0071357) | 4.42677404 |
7 | response to type I interferon (GO:0034340) | 4.36112897 |
8 | cytidine deamination (GO:0009972) | 4.34479307 |
9 | cytidine metabolic process (GO:0046087) | 4.34479307 |
10 | cytidine catabolic process (GO:0006216) | 4.34479307 |
11 | negative regulation of interleukin-12 production (GO:0032695) | 4.26140957 |
12 | lymphocyte chemotaxis (GO:0048247) | 4.02754251 |
13 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.84083708 |
14 | negative regulation of viral genome replication (GO:0045071) | 3.74982714 |
15 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.57951161 |
16 | T cell migration (GO:0072678) | 3.57064116 |
17 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.57026458 |
18 | regulation of defense response to virus by host (GO:0050691) | 3.56602687 |
19 | macrophage activation involved in immune response (GO:0002281) | 3.54764112 |
20 | DNA deamination (GO:0045006) | 3.54745114 |
21 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.51526918 |
22 | folic acid metabolic process (GO:0046655) | 3.50347496 |
23 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.49798024 |
24 | negative regulation of cell killing (GO:0031342) | 3.49798024 |
25 | cellular response to exogenous dsRNA (GO:0071360) | 3.43442000 |
26 | regulation of regulatory T cell differentiation (GO:0045589) | 3.41493744 |
27 | regulation of lymphocyte migration (GO:2000401) | 3.37151264 |
28 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.34885792 |
29 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.33723841 |
30 | macroautophagy (GO:0016236) | 3.32542701 |
31 | regulation of gamma-delta T cell activation (GO:0046643) | 3.31517385 |
32 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.26960397 |
33 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.26960397 |
34 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.26911243 |
35 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.26911243 |
36 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.25142682 |
37 | I-kappaB kinase/NF-kappaB signaling (GO:0007249) | 3.24659065 |
38 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.24631702 |
39 | proteasome assembly (GO:0043248) | 3.24324473 |
40 | nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423) | 3.23861356 |
41 | formation of translation preinitiation complex (GO:0001731) | 3.20774722 |
42 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.20624472 |
43 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.20373406 |
44 | positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517) | 3.20075550 |
45 | regulation of chronic inflammatory response (GO:0002676) | 3.18935529 |
46 | glycine metabolic process (GO:0006544) | 3.18876600 |
47 | regulation of antigen processing and presentation (GO:0002577) | 3.18603130 |
48 | cellular response to interleukin-15 (GO:0071350) | 3.12440305 |
49 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.11735835 |
50 | cytoplasmic pattern recognition receptor signaling pathway (GO:0002753) | 3.08186694 |
51 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.06754635 |
52 | L-phenylalanine metabolic process (GO:0006558) | 3.06754635 |
53 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.02641418 |
54 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.02636004 |
55 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.02434332 |
56 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.01616352 |
57 | defense response to protozoan (GO:0042832) | 3.00093065 |
58 | purine nucleobase biosynthetic process (GO:0009113) | 2.93019382 |
59 | serine family amino acid catabolic process (GO:0009071) | 2.92109234 |
60 | regulation of interleukin-12 production (GO:0032655) | 2.92010686 |
61 | positive regulation of antigen processing and presentation (GO:0002579) | 2.91769585 |
62 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.90295697 |
63 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.88936445 |
64 | cellular response to interferon-beta (GO:0035458) | 2.87378997 |
65 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.87286962 |
66 | regulation of cell killing (GO:0031341) | 2.86622345 |
67 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.86173566 |
68 | lymphocyte migration (GO:0072676) | 2.86116967 |
69 | response to protozoan (GO:0001562) | 2.84581496 |
70 | ribosomal small subunit assembly (GO:0000028) | 2.84519023 |
71 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.84100393 |
72 | regulation of activation of Janus kinase activity (GO:0010533) | 2.83279739 |
73 | regulation of interferon-alpha production (GO:0032647) | 2.82967711 |
74 | interferon-gamma secretion (GO:0072643) | 2.82762744 |
75 | positive regulation of humoral immune response (GO:0002922) | 2.81961202 |
76 | sulfur amino acid catabolic process (GO:0000098) | 2.81838923 |
77 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.80543247 |
78 | response to peptidoglycan (GO:0032494) | 2.80355140 |
79 | immunoglobulin mediated immune response (GO:0016064) | 2.80053303 |
80 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.79192431 |
81 | kynurenine metabolic process (GO:0070189) | 2.78179672 |
82 | myeloid dendritic cell differentiation (GO:0043011) | 2.77525077 |
83 | granulocyte activation (GO:0036230) | 2.77013431 |
84 | indole-containing compound catabolic process (GO:0042436) | 2.76692551 |
85 | indolalkylamine catabolic process (GO:0046218) | 2.76692551 |
86 | tryptophan catabolic process (GO:0006569) | 2.76692551 |
87 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.75066527 |
88 | response to interleukin-15 (GO:0070672) | 2.74320651 |
89 | cysteine metabolic process (GO:0006534) | 2.73978423 |
90 | interferon-gamma production (GO:0032609) | 2.73486341 |
91 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872) | 2.72318564 |
92 | neutrophil activation involved in immune response (GO:0002283) | 2.71723911 |
93 | regulation of T cell tolerance induction (GO:0002664) | 2.71138305 |
94 | aromatic amino acid family catabolic process (GO:0009074) | 2.71002208 |
95 | response to interferon-gamma (GO:0034341) | 2.70953114 |
96 | aldehyde catabolic process (GO:0046185) | 2.70230484 |
97 | rRNA transcription (GO:0009303) | 2.70063650 |
98 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.68248990 |
99 | L-phenylalanine catabolic process (GO:0006559) | 2.68248990 |
100 | cellular response to interferon-gamma (GO:0071346) | 2.68020401 |
101 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.67144115 |
102 | positive regulation of interleukin-1 secretion (GO:0050716) | 2.67056024 |
103 | positive regulation of cell killing (GO:0031343) | 2.66428895 |
104 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.66420660 |
105 | positive regulation by symbiont of host defense response (GO:0052509) | 2.65852002 |
106 | modulation by symbiont of host defense response (GO:0052031) | 2.65852002 |
107 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.65852002 |
108 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.65852002 |
109 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.65852002 |
110 | modulation by symbiont of host immune response (GO:0052553) | 2.65852002 |
111 | cellular defense response (GO:0006968) | 2.65080584 |
112 | folic acid transport (GO:0015884) | 2.64934020 |
113 | amino sugar catabolic process (GO:0046348) | 2.64638950 |
114 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.64000733 |
115 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.62690577 |
116 | positive regulation of B cell mediated immunity (GO:0002714) | 2.62690577 |
117 | regulation of monocyte chemotaxis (GO:0090025) | 2.62134633 |
118 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.60898368 |
119 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.60489976 |
120 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.59969957 |
121 | defense response to virus (GO:0051607) | 2.59704290 |
122 | serine family amino acid metabolic process (GO:0009069) | 2.57028921 |
123 | nucleobase biosynthetic process (GO:0046112) | 2.56842063 |
124 | protein carboxylation (GO:0018214) | 2.56611318 |
125 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.56611318 |
126 | response to interferon-beta (GO:0035456) | 2.55735430 |
127 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.55632547 |
128 | termination of RNA polymerase III transcription (GO:0006386) | 2.55632547 |
129 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.55141513 |
130 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.55135407 |
131 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.55135407 |
132 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.54305413 |
133 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.54259943 |
134 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.54024442 |
135 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.54024442 |
136 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.54024442 |
137 | glyoxylate metabolic process (GO:0046487) | 2.53606330 |
138 | homocysteine metabolic process (GO:0050667) | 2.53160097 |
139 | L-methionine biosynthetic process (GO:0071265) | 2.53069521 |
140 | amino acid salvage (GO:0043102) | 2.53069521 |
141 | L-methionine salvage (GO:0071267) | 2.53069521 |
142 | maturation of SSU-rRNA (GO:0030490) | 2.52819182 |
143 | tryptophan metabolic process (GO:0006568) | 2.52157315 |
144 | sulfur amino acid biosynthetic process (GO:0000097) | 2.50691527 |
145 | ribosomal large subunit biogenesis (GO:0042273) | 2.49967018 |
146 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.48204185 |
147 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.48204185 |
148 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.47452746 |
149 | B cell mediated immunity (GO:0019724) | 2.47353223 |
150 | fructose metabolic process (GO:0006000) | 2.46122580 |
151 | ribosome biogenesis (GO:0042254) | 2.45072461 |
152 | serine family amino acid biosynthetic process (GO:0009070) | 2.44316475 |
153 | viral transcription (GO:0019083) | 2.44106346 |
154 | amino-acid betaine metabolic process (GO:0006577) | 2.42574744 |
155 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.42549817 |
156 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.42163387 |
157 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.40807679 |
158 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.40605478 |
159 | negative regulation of ligase activity (GO:0051352) | 2.40605478 |
160 | regulation of cholesterol esterification (GO:0010872) | 2.37106714 |
161 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.37018358 |
162 | translational termination (GO:0006415) | 2.36833483 |
163 | rRNA modification (GO:0000154) | 2.36423931 |
164 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.35777033 |
165 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.35482281 |
166 | regulation of protein activation cascade (GO:2000257) | 2.35277577 |
167 | endosome to melanosome transport (GO:0035646) | 2.34856430 |
168 | endosome to pigment granule transport (GO:0043485) | 2.34856430 |
169 | NAD biosynthetic process (GO:0009435) | 2.34830463 |
170 | heme transport (GO:0015886) | 2.34763923 |
171 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.33133625 |
172 | methionine metabolic process (GO:0006555) | 2.32370114 |
173 | positive regulation of interferon-beta production (GO:0032728) | 2.31661948 |
174 | methionine biosynthetic process (GO:0009086) | 2.31090041 |
175 | N-acetylneuraminate metabolic process (GO:0006054) | 2.30625953 |
176 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.30121692 |
177 | regulation of RIG-I signaling pathway (GO:0039535) | 2.29691215 |
178 | response to interferon-alpha (GO:0035455) | 2.29403528 |
179 | aromatic amino acid family metabolic process (GO:0009072) | 2.28741807 |
180 | positive regulation of interferon-alpha production (GO:0032727) | 2.28241514 |
181 | skeletal muscle tissue regeneration (GO:0043403) | 2.28136056 |
182 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.27781008 |
183 | pyridine nucleotide biosynthetic process (GO:0019363) | 2.27775087 |
184 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 2.27775087 |
185 | folic acid-containing compound metabolic process (GO:0006760) | 2.26706306 |
186 | NADH metabolic process (GO:0006734) | 2.25923546 |
187 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.25880646 |
188 | regulation of complement activation (GO:0030449) | 2.25574032 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.70367419 |
2 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.18721373 |
3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.17664170 |
4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.94423831 |
5 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.87311553 |
6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.73498628 |
7 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.59527061 |
8 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.58646259 |
9 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.57056598 |
10 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.54725593 |
11 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.47657115 |
12 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.44205607 |
13 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.40356148 |
14 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.29923382 |
15 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.27767267 |
16 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.22964115 |
17 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.22173184 |
18 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.20854079 |
19 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.19791137 |
20 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.13323078 |
21 | MYB_26560356_Chip-Seq_TH2_Human | 2.10814967 |
22 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.09229822 |
23 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.05536249 |
24 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.98415184 |
25 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.95780040 |
26 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.93135554 |
27 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.93078684 |
28 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.92479379 |
29 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.89167357 |
30 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.87242878 |
31 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.82523461 |
32 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.82481056 |
33 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.80261464 |
34 | GATA3_26560356_Chip-Seq_TH2_Human | 1.79801723 |
35 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.76592605 |
36 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.75400265 |
37 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.71142927 |
38 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.70570818 |
39 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.68122646 |
40 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.67389114 |
41 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.67062809 |
42 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.62539821 |
43 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.61758771 |
44 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.61750222 |
45 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.61038968 |
46 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.60596201 |
47 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.56604011 |
48 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.54043864 |
49 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.52638780 |
50 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.51343829 |
51 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.49858465 |
52 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.49844335 |
53 | * MAF_26560356_Chip-Seq_TH1_Human | 1.48275420 |
54 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.47434311 |
55 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.47329281 |
56 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.46633633 |
57 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.46118539 |
58 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.44316952 |
59 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.41636438 |
60 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.40844726 |
61 | SPI1_23127762_ChIP-Seq_K562_Human | 1.40358155 |
62 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.39867974 |
63 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.38531482 |
64 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.38449710 |
65 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.37374683 |
66 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36652254 |
67 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35226303 |
68 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.34718860 |
69 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.32454702 |
70 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.31953242 |
71 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.30888836 |
72 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.29305138 |
73 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.28448066 |
74 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.27987450 |
75 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.24857312 |
76 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.22715856 |
77 | * MYB_26560356_Chip-Seq_TH1_Human | 1.20450252 |
78 | * MAF_26560356_Chip-Seq_TH2_Human | 1.19135333 |
79 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.18940138 |
80 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18860810 |
81 | P300_27268052_Chip-Seq_Bcells_Human | 1.18812744 |
82 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.18750949 |
83 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.18582860 |
84 | UTX_26944678_Chip-Seq_JUKART_Human | 1.18416561 |
85 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.17882029 |
86 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.17319689 |
87 | GATA1_22025678_ChIP-Seq_K562_Human | 1.17290780 |
88 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.16583979 |
89 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.16430815 |
90 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.16336374 |
91 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.16125406 |
92 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.15394264 |
93 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.15378716 |
94 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.15276916 |
95 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.14276010 |
96 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.14263395 |
97 | * E2F1_20622854_ChIP-Seq_HELA_Human | 1.13453178 |
98 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12592301 |
99 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.12452356 |
100 | * BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.12352050 |
101 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.11413156 |
102 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.10790559 |
103 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.10647283 |
104 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.10437280 |
105 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08032013 |
106 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.07876846 |
107 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.07188423 |
108 | SA1_27219007_Chip-Seq_Bcells_Human | 1.06750158 |
109 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.06491440 |
110 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.04805564 |
111 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.04475150 |
112 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.04344975 |
113 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.03755896 |
114 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.02621814 |
115 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.01696990 |
116 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.01108415 |
117 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.01023350 |
118 | * RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.00802840 |
119 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.00543181 |
120 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.99882443 |
121 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.99823927 |
122 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.99591038 |
123 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.99570135 |
124 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.99494551 |
125 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.99375117 |
126 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.97567285 |
127 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.97505076 |
128 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.97221749 |
129 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.97001297 |
130 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.96862634 |
131 | * FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.96817723 |
132 | * FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.96817723 |
133 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.96521692 |
134 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95947065 |
135 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.95912886 |
136 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.95865973 |
137 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.95678049 |
138 | * SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.95616485 |
139 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.95377500 |
140 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.94482642 |
141 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.94361413 |
142 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.94348328 |
143 | * AR_20517297_ChIP-Seq_VCAP_Human | 0.93893966 |
144 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.92232140 |
145 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.92106407 |
146 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.91600119 |
147 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.91412211 |
148 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.91250558 |
149 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.91231047 |
150 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.90277661 |
151 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.90254676 |
152 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.90071807 |
153 | * GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.89822270 |
154 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89505893 |
155 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.88794439 |
156 | * SPI1_20517297_ChIP-Seq_HL60_Human | 0.88397877 |
157 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.88382590 |
158 | ERA_21632823_ChIP-Seq_H3396_Human | 0.87332316 |
159 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.86566528 |
160 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.86429673 |
161 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.85933106 |
162 | * GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.84969282 |
163 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.82722740 |
164 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82658568 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 3.68184860 |
2 | MP0003806_abnormal_nucleotide_metabolis | 3.67859830 |
3 | MP0009840_abnormal_foam_cell | 3.46229465 |
4 | MP0005623_abnormal_meninges_morphology | 3.35767502 |
5 | MP0005360_urolithiasis | 2.86154781 |
6 | MP0005365_abnormal_bile_salt | 2.72335415 |
7 | MP0005085_abnormal_gallbladder_physiolo | 2.69208243 |
8 | MP0009785_altered_susceptibility_to | 2.60162107 |
9 | MP0003186_abnormal_redox_activity | 2.52220213 |
10 | MP0003191_abnormal_cellular_cholesterol | 2.47112316 |
11 | MP0001835_abnormal_antigen_presentation | 2.40949860 |
12 | MP0003436_decreased_susceptibility_to | 2.26201059 |
13 | MP0003693_abnormal_embryo_hatching | 2.00266650 |
14 | MP0003724_increased_susceptibility_to | 1.99153232 |
15 | MP0008875_abnormal_xenobiotic_pharmacok | 1.98348062 |
16 | MP0005058_abnormal_lysosome_morphology | 1.92935370 |
17 | MP0000685_abnormal_immune_system | 1.84943260 |
18 | MP0003195_calcinosis | 1.82848836 |
19 | MP0005025_abnormal_response_to | 1.79420978 |
20 | MP0005332_abnormal_amino_acid | 1.79035240 |
21 | MP0000750_abnormal_muscle_regeneration | 1.78021911 |
22 | MP0001545_abnormal_hematopoietic_system | 1.73771417 |
23 | MP0005397_hematopoietic_system_phenotyp | 1.73771417 |
24 | MP0002277_abnormal_respiratory_mucosa | 1.70999737 |
25 | MP0002148_abnormal_hypersensitivity_rea | 1.69707302 |
26 | MP0010329_abnormal_lipoprotein_level | 1.62679184 |
27 | MP0005319_abnormal_enzyme/_coenzyme | 1.62482178 |
28 | MP0009333_abnormal_splenocyte_physiolog | 1.58464888 |
29 | MP0003656_abnormal_erythrocyte_physiolo | 1.55540205 |
30 | MP0002419_abnormal_innate_immunity | 1.55510634 |
31 | MP0008469_abnormal_protein_level | 1.55406418 |
32 | MP0000609_abnormal_liver_physiology | 1.54392061 |
33 | MP0006082_CNS_inflammation | 1.53484892 |
34 | MP0001853_heart_inflammation | 1.52262737 |
35 | MP0006036_abnormal_mitochondrial_physio | 1.48251373 |
36 | MP0005464_abnormal_platelet_physiology | 1.44120335 |
37 | MP0005671_abnormal_response_to | 1.44105888 |
38 | MP0002138_abnormal_hepatobiliary_system | 1.43856358 |
39 | MP0003300_gastrointestinal_ulcer | 1.41873273 |
40 | MP0005083_abnormal_biliary_tract | 1.41261475 |
41 | MP0001764_abnormal_homeostasis | 1.41100505 |
42 | MP0005000_abnormal_immune_tolerance | 1.40703899 |
43 | MP0009764_decreased_sensitivity_to | 1.38259710 |
44 | MP0004957_abnormal_blastocyst_morpholog | 1.37119613 |
45 | MP0003718_maternal_effect | 1.33895296 |
46 | MP0002723_abnormal_immune_serum | 1.32379260 |
47 | MP0001845_abnormal_inflammatory_respons | 1.29000617 |
48 | MP0003866_abnormal_defecation | 1.28852496 |
49 | MP0002452_abnormal_antigen_presenting | 1.27809672 |
50 | MP0004510_myositis | 1.26831095 |
51 | MP0000858_altered_metastatic_potential | 1.26468089 |
52 | MP0005387_immune_system_phenotype | 1.25020360 |
53 | MP0001790_abnormal_immune_system | 1.25020360 |
54 | MP0002254_reproductive_system_inflammat | 1.23102243 |
55 | MP0001800_abnormal_humoral_immune | 1.21756695 |
56 | MP0003075_altered_response_to | 1.21573200 |
57 | MP0004019_abnormal_vitamin_homeostasis | 1.19683254 |
58 | MP0005451_abnormal_body_composition | 1.16926467 |
59 | MP0001873_stomach_inflammation | 1.16523181 |
60 | MP0003045_fibrosis | 1.16501037 |
61 | MP0002876_abnormal_thyroid_physiology | 1.16024641 |
62 | MP0000598_abnormal_liver_morphology | 1.15005118 |
63 | MP0003646_muscle_fatigue | 1.13935692 |
64 | MP0001819_abnormal_immune_cell | 1.13732465 |
65 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.13621112 |
66 | MP0009643_abnormal_urine_homeostasis | 1.13574835 |
67 | MP0004782_abnormal_surfactant_physiolog | 1.13418389 |
68 | MP0001666_abnormal_nutrient_absorption | 1.13300115 |
69 | MP0004947_skin_inflammation | 1.12915452 |
70 | MP0003252_abnormal_bile_duct | 1.12107865 |
71 | MP0005166_decreased_susceptibility_to | 1.11216244 |
72 | MP0002420_abnormal_adaptive_immunity | 1.10997871 |
73 | MP0010155_abnormal_intestine_physiology | 1.10445118 |
74 | MP0003448_altered_tumor_morphology | 1.10313243 |
75 | MP0002163_abnormal_gland_morphology | 1.07369826 |
76 | MP0002006_tumorigenesis | 1.05411259 |
77 | MP0002118_abnormal_lipid_homeostasis | 1.05149349 |
78 | MP0000343_altered_response_to | 1.04411159 |
79 | MP0006035_abnormal_mitochondrial_morpho | 1.04156656 |
80 | MP0000013_abnormal_adipose_tissue | 1.03325588 |
81 | MP0009763_increased_sensitivity_to | 1.03211578 |
82 | MP0003111_abnormal_nucleus_morphology | 1.02471790 |
83 | MP0003786_premature_aging | 1.01995880 |
84 | MP0000689_abnormal_spleen_morphology | 1.01396361 |
85 | MP0005164_abnormal_response_to | 0.99774397 |
86 | MP0008260_abnormal_autophagy | 0.98484044 |
87 | MP0000490_abnormal_crypts_of | 0.98143502 |
88 | MP0001533_abnormal_skeleton_physiology | 0.97908880 |
89 | MP0002398_abnormal_bone_marrow | 0.96390704 |
90 | MP0002722_abnormal_immune_system | 0.95310340 |
91 | MP0000716_abnormal_immune_system | 0.95266817 |
92 | MP0009278_abnormal_bone_marrow | 0.94110951 |
93 | MP0002396_abnormal_hematopoietic_system | 0.93548124 |
94 | MP0002429_abnormal_blood_cell | 0.93515438 |
95 | MP0009765_abnormal_xenobiotic_induced | 0.93475361 |
96 | MP0002933_joint_inflammation | 0.92862884 |
97 | MP0009697_abnormal_copulation | 0.92749886 |
98 | MP0000604_amyloidosis | 0.91572659 |
99 | MP0002166_altered_tumor_susceptibility | 0.90985523 |
100 | MP0002405_respiratory_system_inflammati | 0.90398798 |
101 | MP0005167_abnormal_blood-brain_barrier | 0.90337807 |
102 | MP0001986_abnormal_taste_sensitivity | 0.90221973 |
103 | MP0004147_increased_porphyrin_level | 0.89569626 |
104 | MP0005379_endocrine/exocrine_gland_phen | 0.88470711 |
105 | MP0003566_abnormal_cell_adhesion | 0.88312643 |
106 | MP0002132_abnormal_respiratory_system | 0.87792591 |
107 | MP0010352_gastrointestinal_tract_polyps | 0.86417823 |
108 | MP0003011_delayed_dark_adaptation | 0.86138943 |
109 | MP0003705_abnormal_hypodermis_morpholog | 0.84760890 |
110 | MP0005376_homeostasis/metabolism_phenot | 0.83357581 |
111 | MP0003221_abnormal_cardiomyocyte_apopto | 0.82958036 |
112 | MP0005266_abnormal_metabolism | 0.81993844 |
113 | MP0003303_peritoneal_inflammation | 0.81359025 |
114 | MP0003763_abnormal_thymus_physiology | 0.80428662 |
115 | MP0002837_dystrophic_cardiac_calcinosis | 0.79661638 |
116 | MP0005636_abnormal_mineral_homeostasis | 0.79613296 |
117 | MP0000358_abnormal_cell_content/ | 0.79043633 |
118 | MP0001501_abnormal_sleep_pattern | 0.77638545 |
119 | MP0003077_abnormal_cell_cycle | 0.76733972 |
120 | MP0005310_abnormal_salivary_gland | 0.76600297 |
121 | MP0009384_cardiac_valve_regurgitation | 0.76492860 |
122 | MP0002019_abnormal_tumor_incidence | 0.76244474 |
123 | MP0002877_abnormal_melanocyte_morpholog | 0.75682612 |
124 | MP0005670_abnormal_white_adipose | 0.75227699 |
125 | MP0004883_abnormal_blood_vessel | 0.74876005 |
126 | MP0005023_abnormal_wound_healing | 0.74735366 |
127 | MP0005395_other_phenotype | 0.73927447 |
128 | MP0001663_abnormal_digestive_system | 0.72533655 |
129 | MP0002693_abnormal_pancreas_physiology | 0.72360802 |
130 | MP0002638_abnormal_pupillary_reflex | 0.71771613 |
131 | MP0008873_increased_physiological_sensi | 0.71442649 |
132 | MP0003690_abnormal_glial_cell | 0.68749199 |
133 | MP0010307_abnormal_tumor_latency | 0.68452712 |
134 | MP0003172_abnormal_lysosome_physiology | 0.67507523 |
135 | MP0002332_abnormal_exercise_endurance | 0.67011531 |
136 | MP0008874_decreased_physiological_sensi | 0.66653470 |
137 | MP0005410_abnormal_fertilization | 0.64555323 |
138 | MP0005165_increased_susceptibility_to | 0.63540204 |
139 | MP0005551_abnormal_eye_electrophysiolog | 0.63526538 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Retinal atrophy (HP:0001105) | 7.62409837 |
2 | Cerebellar dysplasia (HP:0007033) | 6.47668772 |
3 | Type II lissencephaly (HP:0007260) | 6.28082616 |
4 | Hypoplasia of the pons (HP:0012110) | 5.59738721 |
5 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 5.41644700 |
6 | Fatigue (HP:0012378) | 5.31944413 |
7 | Retinal dysplasia (HP:0007973) | 5.26658906 |
8 | Abnormality of the pons (HP:0007361) | 5.22616254 |
9 | Abolished electroretinogram (ERG) (HP:0000550) | 4.15312475 |
10 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 4.00620496 |
11 | Buphthalmos (HP:0000557) | 3.77984582 |
12 | Difficulty climbing stairs (HP:0003551) | 3.74361276 |
13 | Optic neuritis (HP:0100653) | 3.69500926 |
14 | Retrobulbar optic neuritis (HP:0100654) | 3.69500926 |
15 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.69186212 |
16 | IgG deficiency (HP:0004315) | 3.60879362 |
17 | Stomatitis (HP:0010280) | 3.59588508 |
18 | Hyperglycinemia (HP:0002154) | 3.51259976 |
19 | Orchitis (HP:0100796) | 3.49340944 |
20 | Myositis (HP:0100614) | 3.49223733 |
21 | Multiple enchondromatosis (HP:0005701) | 3.35925801 |
22 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.29929225 |
23 | Hyperglycinuria (HP:0003108) | 3.18626964 |
24 | Severe muscular hypotonia (HP:0006829) | 3.12430677 |
25 | Prolonged partial thromboplastin time (HP:0003645) | 3.06219945 |
26 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.00388273 |
27 | Xanthomatosis (HP:0000991) | 2.97348955 |
28 | T lymphocytopenia (HP:0005403) | 2.97108050 |
29 | Abnormality of glycolipid metabolism (HP:0010969) | 2.95926679 |
30 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.95926679 |
31 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.95926679 |
32 | Intrahepatic cholestasis (HP:0001406) | 2.93798140 |
33 | Hypobetalipoproteinemia (HP:0003563) | 2.90166635 |
34 | Abnormality of T cell number (HP:0011839) | 2.88314435 |
35 | Abnormality of glycine metabolism (HP:0010895) | 2.82402356 |
36 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.82402356 |
37 | Hyperammonemia (HP:0001987) | 2.78612593 |
38 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.78455822 |
39 | Encephalitis (HP:0002383) | 2.76847367 |
40 | Recurrent abscess formation (HP:0002722) | 2.76625639 |
41 | Nausea (HP:0002018) | 2.73658374 |
42 | Recurrent bacterial skin infections (HP:0005406) | 2.69408432 |
43 | Increased IgM level (HP:0003496) | 2.61902104 |
44 | Polycythemia (HP:0001901) | 2.60570038 |
45 | Eosinophilia (HP:0001880) | 2.59435807 |
46 | Abnormality of serum amino acid levels (HP:0003112) | 2.57480260 |
47 | Petechiae (HP:0000967) | 2.56306064 |
48 | Keratitis (HP:0000491) | 2.55424170 |
49 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.54805619 |
50 | Abnormality of macrophages (HP:0004311) | 2.53835498 |
51 | Deep venous thrombosis (HP:0002625) | 2.52949084 |
52 | Recurrent fungal infections (HP:0002841) | 2.52471397 |
53 | Pustule (HP:0200039) | 2.52102166 |
54 | Eczematoid dermatitis (HP:0000976) | 2.50620014 |
55 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.45987315 |
56 | Increased serum ferritin (HP:0003281) | 2.44754030 |
57 | Vacuolated lymphocytes (HP:0001922) | 2.44150328 |
58 | Hemoptysis (HP:0002105) | 2.41253734 |
59 | Hypoglycemic coma (HP:0001325) | 2.40560556 |
60 | Keratoconjunctivitis (HP:0001096) | 2.40008620 |
61 | Mediastinal lymphadenopathy (HP:0100721) | 2.39471379 |
62 | Keratoconjunctivitis sicca (HP:0001097) | 2.37799180 |
63 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.37610552 |
64 | Dicarboxylic aciduria (HP:0003215) | 2.37610552 |
65 | Leukocytosis (HP:0001974) | 2.37420023 |
66 | Hyperlipoproteinemia (HP:0010980) | 2.37181341 |
67 | Abnormality of the intrinsic pathway (HP:0010989) | 2.36776939 |
68 | Autoimmune thrombocytopenia (HP:0001973) | 2.36671962 |
69 | Mesangial abnormality (HP:0001966) | 2.35676228 |
70 | Hepatic necrosis (HP:0002605) | 2.35553598 |
71 | Lethargy (HP:0001254) | 2.35534366 |
72 | Pulmonary infiltrates (HP:0002113) | 2.35521613 |
73 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.35079592 |
74 | Vasculitis (HP:0002633) | 2.33703472 |
75 | Granulocytopenia (HP:0001913) | 2.32956920 |
76 | Joint hemorrhage (HP:0005261) | 2.32791895 |
77 | Abnormality of eosinophils (HP:0001879) | 2.30835222 |
78 | Abnormality of T cells (HP:0002843) | 2.30470961 |
79 | Abnormality of the common coagulation pathway (HP:0010990) | 2.30305973 |
80 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.28736408 |
81 | Anorexia (HP:0002039) | 2.28676619 |
82 | Entropion (HP:0000621) | 2.28397571 |
83 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.28275033 |
84 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.28275033 |
85 | Abnormality of iron homeostasis (HP:0011031) | 2.28195058 |
86 | Systemic lupus erythematosus (HP:0002725) | 2.27779011 |
87 | Hypergammaglobulinemia (HP:0010702) | 2.27144022 |
88 | Purpura (HP:0000979) | 2.26673254 |
89 | Meningitis (HP:0001287) | 2.25415341 |
90 | Hypolipoproteinemia (HP:0010981) | 2.24105772 |
91 | Abnormality of the nasal mucosa (HP:0000433) | 2.22064567 |
92 | Abnormal cartilage morphology (HP:0002763) | 2.21565303 |
93 | Myocardial infarction (HP:0001658) | 2.21371357 |
94 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.20310597 |
95 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.19784899 |
96 | Recurrent bronchitis (HP:0002837) | 2.18976710 |
97 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.16598619 |
98 | Thrombocytosis (HP:0001894) | 2.15912883 |
99 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.15450586 |
100 | Gingival bleeding (HP:0000225) | 2.15377171 |
101 | Vertebral compression fractures (HP:0002953) | 2.15282306 |
102 | Tetraparesis (HP:0002273) | 2.14646806 |
103 | Congenital glaucoma (HP:0001087) | 2.13888856 |
104 | Abnormal number of erythroid precursors (HP:0012131) | 2.13143273 |
105 | Nasal polyposis (HP:0100582) | 2.12877833 |
106 | Chronic obstructive pulmonary disease (HP:0006510) | 2.12140538 |
107 | Obstructive lung disease (HP:0006536) | 2.12140538 |
108 | Axonal loss (HP:0003447) | 2.12020445 |
109 | Progressive muscle weakness (HP:0003323) | 2.11181006 |
110 | Reduced antithrombin III activity (HP:0001976) | 2.10003169 |
111 | Poor head control (HP:0002421) | 2.09416938 |
112 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.03779941 |
113 | Recurrent cutaneous fungal infections (HP:0011370) | 2.03779941 |
114 | Gangrene (HP:0100758) | 2.03487887 |
115 | Lissencephaly (HP:0001339) | 2.02735871 |
116 | Joint swelling (HP:0001386) | 2.02695913 |
117 | Hypochromic anemia (HP:0001931) | 2.01868842 |
118 | Gastrointestinal infarctions (HP:0005244) | 2.01816404 |
119 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.01364569 |
120 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.00987238 |
121 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.00987238 |
122 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.00987238 |
123 | Gout (HP:0001997) | 2.00684812 |
124 | Generalized aminoaciduria (HP:0002909) | 2.00229646 |
125 | Prolonged neonatal jaundice (HP:0006579) | 1.99869816 |
126 | Abnormality of methionine metabolism (HP:0010901) | 1.99552809 |
127 | Hyperbilirubinemia (HP:0002904) | 1.99373464 |
128 | Urticaria (HP:0001025) | 1.98516636 |
129 | Complement deficiency (HP:0004431) | 1.97137028 |
130 | Abnormality of vision evoked potentials (HP:0000649) | 1.96082528 |
131 | Increased cerebral lipofuscin (HP:0011813) | 1.95977069 |
132 | Microcytic anemia (HP:0001935) | 1.95969232 |
133 | Cerebral edema (HP:0002181) | 1.95499190 |
134 | Chronic otitis media (HP:0000389) | 1.94923425 |
135 | Exertional dyspnea (HP:0002875) | 1.93400523 |
136 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.92921885 |
137 | Hypoalphalipoproteinemia (HP:0003233) | 1.92814912 |
138 | Epistaxis (HP:0000421) | 1.92530374 |
139 | Fat malabsorption (HP:0002630) | 1.92229456 |
140 | Hepatocellular necrosis (HP:0001404) | 1.91935291 |
141 | 3-Methylglutaconic aciduria (HP:0003535) | 1.91497677 |
142 | Ketosis (HP:0001946) | 1.91253623 |
143 | Abnormality of nucleobase metabolism (HP:0010932) | 1.91042629 |
144 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.90373163 |
145 | Esophageal varix (HP:0002040) | 1.87306952 |
146 | Megalocornea (HP:0000485) | 1.87112255 |
147 | Interstitial pulmonary disease (HP:0006530) | 1.84963323 |
148 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.83512273 |
149 | Recurrent viral infections (HP:0004429) | 1.83412789 |
150 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.83379807 |
151 | Severe global developmental delay (HP:0011344) | 1.82884233 |
152 | Hematochezia (HP:0002573) | 1.82800270 |
153 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.82640527 |
154 | Mucopolysacchariduria (HP:0008155) | 1.82640527 |
155 | Basal ganglia calcification (HP:0002135) | 1.81231854 |
156 | Erythroderma (HP:0001019) | 1.80958527 |
157 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.80511442 |
158 | Increased muscle lipid content (HP:0009058) | 1.80078206 |
159 | Pulmonary embolism (HP:0002204) | 1.79970545 |
160 | Abnormality of T cell physiology (HP:0011840) | 1.79890017 |
161 | CNS demyelination (HP:0007305) | 1.78882762 |
162 | Rough bone trabeculation (HP:0100670) | 1.78335221 |
163 | Rhabdomyolysis (HP:0003201) | 1.78227808 |
164 | Acute hepatic failure (HP:0006554) | 1.78031117 |
165 | Generalized muscle weakness (HP:0003324) | 1.77312040 |
166 | Abnormal albumin level (HP:0012116) | 1.76580845 |
167 | Hypoalbuminemia (HP:0003073) | 1.76580845 |
168 | Recurrent skin infections (HP:0001581) | 1.76091271 |
169 | IgA deficiency (HP:0002720) | 1.76034218 |
170 | Episodic fever (HP:0001954) | 1.75950386 |
171 | Abnormality of the pleura (HP:0002103) | 1.75820868 |
172 | Spontaneous abortion (HP:0005268) | 1.74978373 |
173 | Intellectual disability, profound (HP:0002187) | 1.74396338 |
174 | Myopathic facies (HP:0002058) | 1.74385614 |
175 | Lactic acidosis (HP:0003128) | 1.74272172 |
176 | Gowers sign (HP:0003391) | 1.73864232 |
177 | Abnormality of DNA repair (HP:0003254) | 1.73363326 |
178 | Pachygyria (HP:0001302) | 1.72315526 |
179 | Polyneuropathy (HP:0001271) | 1.71854097 |
180 | Autoimmune hemolytic anemia (HP:0001890) | 1.70444092 |
181 | Chronic diarrhea (HP:0002028) | 1.68520634 |
182 | Poikiloderma (HP:0001029) | 1.68056346 |
Rank | Gene Set | Z-score |
---|---|---|
1 | NME2 | 4.49337682 |
2 | BCKDK | 3.69145250 |
3 | PIM2 | 2.95583376 |
4 | ERN1 | 2.75462722 |
5 | WEE1 | 2.50961133 |
6 | EIF2AK1 | 2.49065100 |
7 | BUB1 | 2.39523033 |
8 | EIF2AK3 | 2.30236907 |
9 | TYK2 | 2.28770752 |
10 | TBK1 | 2.25788115 |
11 | ADRBK2 | 2.14647726 |
12 | TAOK3 | 1.99382924 |
13 | EPHA2 | 1.90220802 |
14 | KDR | 1.81801114 |
15 | IRAK3 | 1.79728724 |
16 | GRK7 | 1.74884626 |
17 | PTK2B | 1.73685926 |
18 | MAP3K14 | 1.71089190 |
19 | TRIB3 | 1.69797998 |
20 | IKBKB | 1.66643701 |
21 | FRK | 1.65384737 |
22 | ZAP70 | 1.62873669 |
23 | EPHA3 | 1.62227353 |
24 | STK11 | 1.61798659 |
25 | ARAF | 1.60509688 |
26 | MAP4K2 | 1.60483845 |
27 | FLT3 | 1.52860811 |
28 | FGFR4 | 1.51349345 |
29 | BMPR2 | 1.49574051 |
30 | MAP4K1 | 1.49105097 |
31 | BLK | 1.47661141 |
32 | ACVR1B | 1.43040109 |
33 | RPS6KA4 | 1.42211963 |
34 | JAK3 | 1.40965642 |
35 | MAP2K3 | 1.36673299 |
36 | IKBKE | 1.33579385 |
37 | PIK3CG | 1.32039498 |
38 | NEK1 | 1.31068746 |
39 | KIT | 1.29777410 |
40 | STK16 | 1.27126551 |
41 | BRSK2 | 1.26976757 |
42 | ABL2 | 1.26035304 |
43 | TNK2 | 1.25458563 |
44 | PIM1 | 1.23656091 |
45 | ITK | 1.22229378 |
46 | MAP3K3 | 1.21798362 |
47 | IRAK1 | 1.21286144 |
48 | TAOK1 | 1.19236858 |
49 | LCK | 1.17074879 |
50 | NEK2 | 1.16850304 |
51 | LRRK2 | 1.10177706 |
52 | MAP3K11 | 1.09628400 |
53 | DYRK3 | 1.08374177 |
54 | FES | 1.07796825 |
55 | IRAK4 | 1.06950655 |
56 | PINK1 | 1.05328200 |
57 | NEK9 | 1.05275410 |
58 | RIPK4 | 1.04930155 |
59 | DAPK2 | 1.00182161 |
60 | TESK2 | 0.99182992 |
61 | PDK3 | 0.98110337 |
62 | PDK4 | 0.98110337 |
63 | EPHB1 | 0.97941545 |
64 | PDK2 | 0.96093989 |
65 | STK10 | 0.90908941 |
66 | PRKCQ | 0.88578888 |
67 | TAOK2 | 0.88489037 |
68 | MAPK11 | 0.87658341 |
69 | GRK1 | 0.85688851 |
70 | MATK | 0.85468136 |
71 | LMTK2 | 0.83975833 |
72 | MYLK | 0.83884103 |
73 | TIE1 | 0.83394559 |
74 | MAPKAPK3 | 0.82768551 |
75 | HCK | 0.80292315 |
76 | AKT3 | 0.79935244 |
77 | MAP3K13 | 0.79627405 |
78 | TSSK6 | 0.79105741 |
79 | PKN2 | 0.78283758 |
80 | TGFBR2 | 0.77087160 |
81 | TLK1 | 0.75945420 |
82 | RPS6KB2 | 0.74974129 |
83 | EIF2AK2 | 0.73990569 |
84 | CSK | 0.73931686 |
85 | MAP3K8 | 0.72461671 |
86 | NLK | 0.72224235 |
87 | CDK4 | 0.71857710 |
88 | MAP2K6 | 0.71642599 |
89 | STK4 | 0.71151885 |
90 | BTK | 0.70235624 |
91 | SYK | 0.70225552 |
92 | TESK1 | 0.69760120 |
93 | BRAF | 0.68864812 |
94 | PRKCH | 0.68327705 |
95 | FGR | 0.68312026 |
96 | CDK19 | 0.67527578 |
97 | ILK | 0.66234120 |
98 | CLK1 | 0.65567703 |
99 | MST4 | 0.65530686 |
100 | MAP3K10 | 0.65171649 |
101 | PLK1 | 0.62995051 |
102 | PAK4 | 0.62928328 |
103 | CHUK | 0.62860898 |
104 | TGFBR1 | 0.62490362 |
105 | MAP3K5 | 0.61859995 |
106 | PBK | 0.61118667 |
107 | JAK1 | 0.60272066 |
108 | TEC | 0.58739300 |
109 | JAK2 | 0.55487153 |
110 | GRK6 | 0.54062642 |
111 | TXK | 0.53647961 |
112 | PLK4 | 0.52617535 |
113 | LYN | 0.52527487 |
114 | AURKB | 0.52434518 |
115 | VRK1 | 0.51661560 |
116 | PIK3CA | 0.51416513 |
117 | HIPK2 | 0.51405817 |
118 | CSF1R | 0.48074641 |
119 | MARK3 | 0.47827668 |
120 | DAPK3 | 0.46717971 |
121 | WNK4 | 0.46086448 |
122 | ZAK | 0.44891418 |
123 | MAP2K2 | 0.44283588 |
124 | CSNK2A1 | 0.43779795 |
125 | PAK1 | 0.43423694 |
126 | PRKCD | 0.43171266 |
127 | IRAK2 | 0.42120491 |
128 | TTN | 0.41545609 |
129 | NUAK1 | 0.41102867 |
130 | RPS6KA6 | 0.40493290 |
131 | PDK1 | 0.40484397 |
132 | RPS6KA5 | 0.39308348 |
133 | PRKD2 | 0.39254732 |
134 | MAP3K1 | 0.39130005 |
135 | FGFR3 | 0.38121216 |
136 | MUSK | 0.35916929 |
137 | CAMKK2 | 0.35906606 |
138 | OXSR1 | 0.34541591 |
139 | FYN | 0.32554449 |
140 | PKN1 | 0.32357952 |
141 | MAPK15 | 0.30331089 |
142 | IGF1R | 0.28656056 |
143 | ABL1 | 0.28517117 |
144 | ADRBK1 | 0.28002241 |
145 | PRKG2 | 0.27496630 |
146 | MAP2K7 | 0.26300655 |
147 | PDPK1 | 0.24459078 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Proteasome_Homo sapiens_hsa03050 | 3.22211542 |
2 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.17951238 |
3 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.81824003 |
4 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.79933700 |
5 | Asthma_Homo sapiens_hsa05310 | 2.77953250 |
6 | Ribosome_Homo sapiens_hsa03010 | 2.31592867 |
7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.29916015 |
8 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.22157364 |
9 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.21550766 |
10 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.18940947 |
11 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 2.13244019 |
12 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.12623673 |
13 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.10986097 |
14 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.02791432 |
15 | RNA polymerase_Homo sapiens_hsa03020 | 2.01230964 |
16 | Sulfur relay system_Homo sapiens_hsa04122 | 1.98065085 |
17 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.96792120 |
18 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.91858633 |
19 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.81793571 |
20 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.78522532 |
21 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.74170886 |
22 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.72824122 |
23 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.70368147 |
24 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.69798834 |
25 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.68962169 |
26 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.66517552 |
27 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.66073259 |
28 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.65880546 |
29 | DNA replication_Homo sapiens_hsa03030 | 1.62276614 |
30 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.61770208 |
31 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.58075453 |
32 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.55814218 |
33 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.53459286 |
34 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.52870354 |
35 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.52139659 |
36 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.52121757 |
37 | Mismatch repair_Homo sapiens_hsa03430 | 1.49686268 |
38 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.47959901 |
39 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.47539087 |
40 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.46384712 |
41 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.39409633 |
42 | Peroxisome_Homo sapiens_hsa04146 | 1.37548265 |
43 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.37330816 |
44 | Carbon metabolism_Homo sapiens_hsa01200 | 1.35686386 |
45 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.35400773 |
46 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.33956594 |
47 | Tuberculosis_Homo sapiens_hsa05152 | 1.33751929 |
48 | Viral myocarditis_Homo sapiens_hsa05416 | 1.32033116 |
49 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.31507475 |
50 | Legionellosis_Homo sapiens_hsa05134 | 1.31271715 |
51 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.30959361 |
52 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.28766079 |
53 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.27821922 |
54 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.25701879 |
55 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.25422927 |
56 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.22430050 |
57 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.20743535 |
58 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.18981058 |
59 | Other glycan degradation_Homo sapiens_hsa00511 | 1.18727657 |
60 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.18280550 |
61 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.14761582 |
62 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.13552309 |
63 | Phagosome_Homo sapiens_hsa04145 | 1.09882898 |
64 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.02768466 |
65 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.02451209 |
66 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.00890892 |
67 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.99399308 |
68 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.98026038 |
69 | Histidine metabolism_Homo sapiens_hsa00340 | 0.96202501 |
70 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.94592339 |
71 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.94454214 |
72 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.93955295 |
73 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.93909393 |
74 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.93905212 |
75 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.93055062 |
76 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.92757734 |
77 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.92339869 |
78 | Salmonella infection_Homo sapiens_hsa05132 | 0.90407464 |
79 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.89105324 |
80 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.87901382 |
81 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.87391182 |
82 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.87217255 |
83 | Base excision repair_Homo sapiens_hsa03410 | 0.86689152 |
84 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.86472413 |
85 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.85815704 |
86 | Leishmaniasis_Homo sapiens_hsa05140 | 0.85705242 |
87 | Allograft rejection_Homo sapiens_hsa05330 | 0.83930825 |
88 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.83807031 |
89 | Galactose metabolism_Homo sapiens_hsa00052 | 0.83724520 |
90 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.83529557 |
91 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.83210736 |
92 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.81623864 |
93 | Hepatitis C_Homo sapiens_hsa05160 | 0.81259084 |
94 | Lysosome_Homo sapiens_hsa04142 | 0.80596430 |
95 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.80451815 |
96 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.78207710 |
97 | Homologous recombination_Homo sapiens_hsa03440 | 0.76145517 |
98 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.75508809 |
99 | Measles_Homo sapiens_hsa05162 | 0.75432871 |
100 | RNA transport_Homo sapiens_hsa03013 | 0.75205043 |
101 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.73310925 |
102 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.71555562 |
103 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.70907066 |
104 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.70824592 |
105 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.70147534 |
106 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.69454392 |
107 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.68925652 |
108 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.68044412 |
109 | Retinol metabolism_Homo sapiens_hsa00830 | 0.67540788 |
110 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.67157280 |
111 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.66914562 |
112 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.65011500 |
113 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.64604197 |
114 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.63860236 |
115 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.62437554 |
116 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.61404913 |
117 | Metabolic pathways_Homo sapiens_hsa01100 | 0.59916429 |
118 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.58244090 |
119 | Purine metabolism_Homo sapiens_hsa00230 | 0.57753325 |
120 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.56177542 |
121 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.54483164 |
122 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.53720483 |
123 | Pertussis_Homo sapiens_hsa05133 | 0.52516146 |
124 | Shigellosis_Homo sapiens_hsa05131 | 0.51322026 |
125 | Apoptosis_Homo sapiens_hsa04210 | 0.50860810 |
126 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.50810849 |
127 | Spliceosome_Homo sapiens_hsa03040 | 0.50760456 |
128 | Influenza A_Homo sapiens_hsa05164 | 0.50425852 |
129 | Parkinsons disease_Homo sapiens_hsa05012 | 0.50109920 |
130 | Malaria_Homo sapiens_hsa05144 | 0.49224057 |
131 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.49019786 |
132 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.47892436 |
133 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.47692994 |
134 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.46490011 |
135 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.46423890 |
136 | ABC transporters_Homo sapiens_hsa02010 | 0.45648542 |
137 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.45601500 |
138 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.41773544 |
139 | Mineral absorption_Homo sapiens_hsa04978 | 0.37051483 |
140 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.36655256 |
141 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.30779168 |
142 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.30123369 |
143 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.28293240 |
144 | Hepatitis B_Homo sapiens_hsa05161 | 0.26419344 |
145 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.25680314 |
146 | Alzheimers disease_Homo sapiens_hsa05010 | 0.25120947 |
147 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.24575808 |
148 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.24571636 |
149 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.23919216 |
150 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.23919062 |
151 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.18466988 |
152 | Huntingtons disease_Homo sapiens_hsa05016 | 0.12673232 |